Consumer & Healthcare
Allbirds sinks as 582% AI surge comes to screeching halt
The company says that it plans to rebrand itself as NewBird AI
Abbott cuts profit forecast in wake of cancer-screening deal
It still projects full-year 2026 comparable sales growth of 6.5% to 7.5%
Luxury giants slump as Gulf demand seizes up due to war
The war in the Middle East has disrupted oil and gas supplies and darkened the economic outlook with fears of a global inflation crisis
Jury finds Live Nation acts as a monopoly in a victory for states
A US Federal jury on Wednesday found that Live Nation, the concert giant that owns Ticketmaster, has operated as a monopoly in violation of federal and state antitrust laws, ending a closely watched t...
Remote working, prices drive US home coffee consumption to highest in 14 years
Coffee prices in the US remain historically high
LVMH sales disappoint as Middle East war crimps Dior demand
There are signs that the more exclusive brands are holding up better during the slump
Singapore-listed iX Biopharma bets big on non-opioid pain relief
Its flagship drug Wafermine is a sublingual ketamine wafer that delivers rapid pain relief without addiction risks
GSK sees blockbuster potential in targeted cancer therapy after promising early data
[LONDON] British drugmaker GSK’s experimental targeted cancer drug Mo-rez has blockbuster potential, its head of oncology research has told reporters, after early data showed the drug helped shrink tu...
Hermes sticks with plan to raise output even as war sours mood
The company’s leather-goods plants are all in France and typically employ about 260 artisans
Auditors flag uncertainty on Katrina Group’s ability to continue as a going concern
This hinges on liabilities exceeding assets by S$18.4 million as well as litigation brought by the Urban Redevelopment Authority
